Li demonstrated that immunoreactive scores of FGF1 were higher in NSCLC specimens than in peritumoral normal tissues and patients with high FGF1 expression had a lower overall survival rate [12]. This evidence concerns the gene FGF1 and non-small cell lung carcinoma.